with limited stocks soon to be offered to those most in need
Highly restrictive diets may lead to deficiencies that make it difficult to heal after surgery
Two questions come up constantly from patients in the BMI 30 to 40 range: whether medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) are an option, and how they compare to surgery at that weight range
According to the World Health Organization (WHO), over 55 million people worldwide live with some form of dementia, with approximately 10 million new cases reported each year
The retatrutide vs semaglutide comparison explores this next-generation option
This provides a theoretical basis for uncertainty management, serving as a crucial caveat for clinicians: when utilizing GLP-1RAs, one must distinguish between the relative certainty of metabolic benefits and the stochastic nature of reproductive improvements